A Study to Evaluate INCA036873 in Participants With Advanced Solid Tumors and Hematological Malignancies
Incyte Corporation
Incyte Corporation
Zumutor Biologics Inc.
Monte Rosa Therapeutics, Inc
OncoNano Medicine, Inc.
Incyte Corporation
Nurix Therapeutics, Inc.
Novartis
Shattuck Labs, Inc.
RenJi Hospital
Seagen Inc.
Celldex Therapeutics
City of Hope Medical Center
Eastern Cooperative Oncology Group
Celgene
University of South Florida
Roswell Park Cancer Institute
Incyte Corporation
Jonsson Comprehensive Cancer Center
Pfizer
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
University of Wisconsin, Madison
Vanderbilt-Ingram Cancer Center
City of Hope Medical Center
National Institutes of Health Clinical Center (CC)
Vanderbilt-Ingram Cancer Center
Wake Forest University Health Sciences
Seagen Inc.
Masonic Cancer Center, University of Minnesota
Masonic Cancer Center, University of Minnesota
Wake Forest University Health Sciences
Fred Hutchinson Cancer Center
OHSU Knight Cancer Institute
OHSU Knight Cancer Institute
University of Louisville
OHSU Knight Cancer Institute
Fred Hutchinson Cancer Center
Rutgers, The State University of New Jersey
Columbia University
Regeneron Pharmaceuticals
Regeneron Pharmaceuticals
Barbara Ann Karmanos Cancer Institute
Rutgers, The State University of New Jersey
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Vanderbilt University
Indiana University
University of Minnesota
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
National Cancer Institute (NCI)